Dizal (Jiangsu) Pharmaceutical Co., Ltd. Stock
Equities
688192
CNE1000055W8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.48 CNY | -1.21% | -0.07% | -11.22% |
Sales 2023 | 91.29M 12.64M | Sales 2024 * | 401M 55.59M | Capitalization | 17.66B 2.45B |
---|---|---|---|---|---|
Net income 2023 | -1.11B -153M | Net income 2024 * | -1.01B -140M | EV / Sales 2023 | 214 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 44 x |
P/E ratio 2023 |
-17.6
x | P/E ratio 2024 * |
-17.4
x | Employees | 424 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 18.47% |
1 day | -1.21% | ||
1 week | -0.07% | ||
Current month | -5.70% | ||
1 month | +14.16% | ||
3 months | +35.94% | ||
6 months | -2.57% | ||
Current year | -11.22% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 17-09-30 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 20-09-06 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 20-09-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 42.48 | -1.21% | 1,415,768 |
24-05-15 | 43 | -0.19% | 1,659,841 |
24-05-14 | 43.08 | +3.86% | 3,439,891 |
24-05-13 | 41.48 | +1.72% | 2,862,931 |
24-05-10 | 40.78 | -4.07% | 2,833,072 |
End-of-day quote Shanghai S.E., May 15, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.22% | 2.45B | |
+8.29% | 114B | |
+10.21% | 104B | |
0.00% | 22.28B | |
-11.90% | 22.41B | |
-4.55% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- 688192 Stock